Position in NBIX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,853
+$404 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#735
of 768 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SouthState Bank Corp holds $68,844 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
522 | $37,510 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
545 | $13,412 | |
| 3 | VTRS |
Viatris Inc
|
562 | $8,924 | |
| 4 | ALKS |
Alkermes plc.
|
99 | $5,187 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
11 | $1,853 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
2 | $1,083 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
25 | $866 | |
| 8 | CGC |
Canopy Growth Corp
|
10 | $9 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,853 | 11 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,449 | 11 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,560 | 11 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,544 | 11 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,382 | 11 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $3,871 | 35 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||